Article

STAAR's ICL wins spot on FDA's fast-track list

Monrovia, CA-The FDA is studying STAAR Surgical Co.'s implantable contact lens (ICL) under an expedited review status that calls the product a potentially revolutionary advance over the current market.

Related Videos
Dr. Analisa Arosemena discusses glaucoma at EyeCon 2024
Dr. Amir Ghanipour discusses light adjustable lenses for cataracts at EyeCon 2024
© 2024 MJH Life Sciences

All rights reserved.